Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MHZ3: a key regulator of ethylene signaling in rice.

aBIOTECH·2025
Same author

Effect of sakuranetin against cyclophosphamide-induced immunodeficiency mice: role of IFN-γ/TNF-α/IgG/IgM/interleukins.

Naunyn-Schmiedeberg's archives of pharmacology·2025
Same author

SLC19A1 Gene Polymorphism; Risk Factor for Preeclampsia.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2025
Same author

piRNAs in leukemogenesis: Mechanisms, biomarkers, and therapeutic implications.

Clinica chimica acta; international journal of clinical chemistry·2025
Same author

Exosome-based miRNA delivery: Transforming cancer treatment with mesenchymal stem cells.

Regenerative therapy·2025
Same author

miR-210: A non-invasive biomarker for hypoxia-driven lung cancer diagnosis and therapy.

Clinica chimica acta; international journal of clinical chemistry·2025

Related Experiment Video

Updated: Jun 18, 2026

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

IMRT quality assurance using a second treatment planning system.

Muhammad Naeem Anjum1, William Parker, Russell Ruo

  • 1McGill University Health Center, Department of Medical Physics, Montreal General Hospital, Quebec, Canada.

Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|December 1, 2009
PubMed
Summary

This study validates the Varian Eclipse treatment planning system (TPS) for independent quality assurance (QA) of intensity-modulated radiation therapy (IMRT) plans. Eclipse provides accurate and efficient patient-specific IMRT QA, enhancing treatment safety.

More Related Videos

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
05:18

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources

Published on: October 6, 2023

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Related Experiment Videos

Last Updated: Jun 18, 2026

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
08:25

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
05:18

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources

Published on: October 6, 2023

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiotherapy Quality Assurance

Background:

  • Patient-specific quality assurance (QA) is crucial for intensity-modulated radiation therapy (IMRT).
  • Independent verification of dose calculations ensures treatment accuracy.
  • Treatment planning systems (TPS) are central to IMRT dose calculation.

Purpose of the Study:

  • To evaluate the Varian Eclipse TPS as an independent tool for patient-specific IMRT QA.
  • To compare dose calculations between the Nomos Corvus TPS and Varian Eclipse TPS.
  • To assess the accuracy and efficiency of Eclipse for IMRT QA.

Main Methods:

  • Generated IMRT QA plans for 24 patients using the Nomos Corvus TPS.
  • Recalculated doses using the Varian Eclipse TPS for independent verification.
  • Compared calculated doses with ion chamber measurements and radiochromic film data.
  • Analyzed absolute and relative dose distributions using gamma index criteria (3%/3mm and 5%/3mm).

Main Results:

  • Eclipse and Corvus TPS showed excellent agreement for ion chamber doses (mean ratio 0.999).
  • Eclipse and Corvus demonstrated high agreement for 2D dose analysis (94.4% pixels passing 3%/3mm criteria).
  • Both TPS correlated well with film measurements, with Eclipse showing slightly better agreement than Corvus.

Conclusions:

  • The Varian Eclipse TPS is a feasible, accurate, and robust tool for independent patient-specific IMRT QA.
  • Eclipse offers a time-efficient method for enhancing IMRT treatment safety.
  • Independent TPS verification is a valuable component of comprehensive IMRT QA protocols.